Larvol Delta - OpenLabel-SingleArm-Phase-IbIi-Study-of-Immune-Combination-Therapy-with-Belantamab-Mafodotin-and-Elotuzumab-in-Patients-with-RelapsedRefractory-Multiple-Myeloma-RRMM

mezigdomide (CC-92480) - BMS

Abecma (idecabtagene vicleucel) - BMS

https://imsannual2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=TU1XRFNPTlIyMjY0Nw&PosterID=826923&rnd=0.6544994

Murali Janakiram, MD, MS

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next